Navigation Links
VWR Funding, Inc. to Hold First Quarter 2008 Financial Results Conference Call
Date:5/7/2008

WEST CHESTER, Pa., May 7 /PRNewswire/ -- VWR Funding, Inc., the parent company of VWR International, LLC, a leading global laboratory supply company, will hold a conference call on Monday, May 19th to discuss its first quarter financial results.

Who: John M. Ballbach, Chairman, President and CEO

Jack L. Wyszomierski, Executive Vice-President & Chief Financial

Officer

When: Monday, May 19, 2008

9:00 a.m. Eastern Time (ET)

How: Interested parties may participate by dialing (877) 719-9801 (U.S.

and Canada) or 719-325-4785 (outside U.S. and Canada). A replay

of the call will be available from 12:00 p.m. ET on May 19, 2008

through midnight May 26, 2008 by dialing 888-203-1112 (U.S. and

Canada) or 719-457-0820 (outside U.S. and Canada), pass code for

both replay numbers: 4181472.

Information:

VWR Funding's Quarterly Report on Form 10-Q for the quarter ended March 31, 2008 will be filed on or before May 13, 2008 with the Securities and Exchange Commission.

About VWR International, LLC

VWR International is a leading global laboratory supply company with worldwide sales of $3.5 billion US dollars. VWR International's business is highly diversified across products and services, geographic regions and customer segments. The company offers products from a wide range of manufacturers to a large number of customers primarily in North America, Europe and Asia. VWR International's principal customers are major pharmaceutical, biotechnology, industrial and government organizations as well as universities and schools. VWR International distributes a diversified product mix, including chemicals, glassware and plasticware, equipment and instruments, furniture, protective apparel, production and safety products, and other life science and laboratory products and supplies. VWR International supports its cust
'/>"/>

SOURCE VWR Funding, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. VWR Funding, Inc. to Hold Fourth Quarter and Year-End 2007 Financial Results Conference Call
2. VWR Funding, Inc. to Hold Third Quarter 2007 Financial Results Conference Call
3. Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results
4. NeurogesX to Report First Quarter 2008 Financial Results
5. Oncothyreon Reports First Quarter 2008 Financial Results
6. Jazz Pharmaceuticals, Inc. to Announce First Quarter Results on May 13, 2008
7. iCAD Reports First Quarter 2008 Financial Results
8. SurgiQuest Announces First Single Port Procedure for Ovary Removal Using AirSeal(TM) Access System
9. AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results
10. American Oriental Bioengineering Reports First Quarter 2008 Financial Results
11. Advanced Life Sciences Announces First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 Carahsoft and CDS Federal ... 23, 2014 at 2pm EST (11am PST), “Natural Language ... focuses on how technology can turn raw, heterogeneous data ... government agencies. The online webinar will last approximately one ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider of ... regulatory, business, and media events in the United States ... former associate Virginia Cox , JD, is returning to the ... Virginia Cox re-joins 3D after more than two years of ...
(Date:1/14/2014)... EquitiesIQ, a leading informational research provider, has ... an emerging biomedical company acquiring, developing, manufacturing, and marketing ... Free report download: http://equitiesiq.com/reports/alliqua/ , In late ... and Board, which launched the company’s new strategy to ...
(Date:1/14/2014)... SAN DIEGO and BETHESDA, Md. ... they are joining together with two institutes from the ... more reliable tools for bringing safer, more effective treatments ... with the National Center for Advancing Translational Sciences (NCATS) ...
Breaking Biology Technology:Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3
... and EMERYVILLE, Calif., May 14 Bayer HealthCare Pharmaceuticals, ... ) today announced that more than 65 studies evaluating ... at the 2009 American Society of Clinical Oncology (ASCO) ... cancers - in the treatment of unresectable hepatocellular carcinoma ...
... and Phase 1 safety studies, and plans for Phase ... (BPH) are to be presentedCINCINNATI, May 14 Ausio ... for an aging global population, will lead off the ... 2009 at 9:00 AM in Atlanta, Georgia. Ausio has ...
... Non-Invasive Imaging to Demonstrate Mechanism of Action and Positive ... VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), ... for the treatment of cardiovascular and metabolic disease, today ... 2 clinical trial of its lead drug, VIA-2291 in ...
Cached Biology Technology:Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 2Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 3Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 4Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 5Bayer and Onyx Announce Nexavar Data Presentations at 45th American Society of Clinical Oncology Annual Meeting 6Ausio Pharmaceuticals to Present at Bio(R) 2009 2VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients 2VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients 3VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients 4VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients 5
(Date:4/23/2014)... 2 million Food Standards Agency (FSA) project to map ... workers. , Norovirus outbreaks can rapidly affect large ... frozen strawberries infected 11,000 people in Germany, but there ... strains cause infection and which foods are the most ... will produce data that will help the FSA to ...
(Date:4/22/2014)... will lead a five-year, $3 million study to determine ... the transport of dissolved organic matter (DOM) through the ... the chemical composition and water quality of the watershed ... National Science Foundation,s MacroSystems Biology program, researchers will collect ... begins in Canada and runs through five U.S. states, ...
(Date:4/22/2014)... Calif. Inspired by the fist-like club of ... University of California, Riverside, in collaboration with University of ... structure for composite materials that is more impact resistant ... "The more we study the club of this tiny ... so many things we use every day," said David ...
Breaking Biology News(10 mins):Connecticut River watershed study will assess impacts of extreme rain events 2Connecticut River watershed study will assess impacts of extreme rain events 3Mantis shrimp stronger than airplanes 2Mantis shrimp stronger than airplanes 3
... the body of pathogens. As important as resisting infection, is ... toxins produced by pathogens or by components of the host ... damage inflicted to different tissues and organs that, if uncontrolled, ... , The in-built capacity that an infected individual has ...
... LANSING, Mich. In the current issue of Science ... virus evolves, which sheds light on how easy it can ... showed for the first time how the virus called "Lambda" ... an innovation that took four mutations to accomplish. This virus ...
... magician employing sleight of hand, the protein mitoNEET -- a ... draws the eye with a flurry of movement in one ... else. Using a combination of laboratory experiments and computer ... San Diego (UCSD) have deciphered part of mitoNEET,s movements to ...
Cached Biology News:European Research Council supports search for regulators of tissue damage 2MSU researchers show how new viruses evolve, and in some cases, become deadly 2Rice, UCSD scientists probe form, function of mysterious protein 2Rice, UCSD scientists probe form, function of mysterious protein 3
... assay kit designed to detect poly(ADP-ribose) polymerase ... an enzyme implicated in DNA damage and ... by caspase-3. Cleavage of PARP from the ... a hallmark of apoptosis. Each kit is ...
... comes with a shutter (controlled via a TTL ... The DH-2000 Deuterium Tungsten Halogen Light ... tungsten halogen light sources in a single optical ... stable output from 215-200 nm. In addition, deep-UV ...
... The MSD Security ChemStation ... GC/MS software application for ... quantification, library searching and ... aspects of data security, ...
... genome-wide microRNA expression profiling and built ... microfluidic on-chip synthesis platform. These microarrays ... comprehensive microRNA Expression Profiling Service. ... Nematode microRNA Microarray contains all known ...
Biology Products: